KROS Keros Therapeutics, Inc. - common stock
$10,28
Cena · Sie 18, 2026
Dane fundamentalne na dzień Sie 3, 2026
Zakres 52 tyg.
$10–$23
5% of range
Ocena Analityków
BUY
14 analysts
Cena Docelowa
$20
+93% upside
P/E (TTM)
4.5
ROE
17.2%
Marża Zysku Netto
35.7%
KROS Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$10.28
Kapitalizacja Rynkowa
$201M
P/E (TTM)
4.5
EPS (TTM)
$2.30
Przychody (TTM)
$244M
Stopa dywidendy
—
ROE
17.2%
D/E Dług/Kapitał
—
Zakres 52 tyg.
$10 – $23
KROS Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
$244M
2019-12-31
→
2025-12-31
EPS
$2.30
2020-12-31
→
2025-12-31
Wolny przepływ pieniężny
$106M
2020-12-31
→
2025-12-31
Marże
35.7%
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
KROS
Mediana porównawcza
P/E (TTM)
4.5
1.2
P/S (TTM)
0.8
6.3
P/B
0.7
1.6
Price / FCF (Cena / FCF)
1.9
—
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
KROS
Mediana porównawcza
Operating Margin (Marża Operacyjna)
27.7%
—
Net Profit Margin (Marża Zysku Netto)
35.7%
-312.6%
ROA
18.2%
-56.8%
ROE
17.2%
-83.3%
ROIC
21.1%
—
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
KROS
Mediana porównawcza
Current Ratio (Wskaźnik bieżący)
15.5
8.5
Quick Ratio (Wskaźnik Szybkości)
14.3
—
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
KROS
Mediana porównawcza
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
KROS
Mediana porównawcza
KROS Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
KUP
14 analityków
- Mocne kupno 3 21,4%
- Kup 6 42,9%
- Trzymaj 5 35,7%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
6 analityków · 2026-08-18
Mediana
$19.00
Średnia
$19.83
← Poniżej wszystkich celów
$10.28
Niski
$16.00
Wysoki
$25.00
Średni cel
$19.00
+84,8%
Średnia cel
$19.83
+92,9%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
0.78%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 30 czerwca 2026 | $-1.45 | $-1.37 | -0.08% |
| 31 marca 2026 | $-1.21 | $-1.04 | -0.17% |
| 31 grudnia 2025 | $-0.86 | $-0.64 | -0.22% |
| 30 września 2025 | $-0.18 | $-1.07 | 0.89% |
| 30 czerwca 2025 | $-0.76 | $-1.15 | 0.39% |
| 31 marca 2025 | $3.62 | $-0.25 | 3.9% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| KROS | $398M | 8.9 | — | 35.7% | 17.2% | — |
| NERV | $174M | -0.1 | — | — | 339.5% | — |
| IVVD | $697M | -8.2 | 110.5% | -98.2% | -36.9% | — |
| TNXP | $200M | -1.1 | 29.8% | -946.2% | -60.0% | — |
| WHWK | $114M | -7.3 | -72.5% | -288.3% | -13.4% | — |
| PEPG | $448M | -3.1 | — | — | -82.0% | — |
| DTIL | $100M | -1.2 | -50.1% | -133.4% | -72.4% | — |
| CRBP | $143M | -1.4 | — | — | -60.8% | — |
| KRRO | $75M | -0.6 | 181.5% | -1834.5% | -140.8% | — |
| ABOS | $128M | -1.1 | — | — | -129.4% | — |
| CUE | $29M | -1.1 | 195.8% | -96.9% | -119.3% | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 14
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $244M | $0 | $151.0K | $0 | $20M | $0 | $10M | |
| R&D Expense | $130M | $174M | $135M | $87M | $55M | $34M | $17M | |
| SG&A Expense | $47M | $41M | $35M | $28M | $21M | $13M | $3M | |
| Operating Expenses | $176M | $214M | $170M | $115M | $76M | $47M | $21M | |
| Operating Income | $68M | $-211M | $-170M | $-115M | $-56M | $-47M | $-11M | |
| Other Non-op | $-539.0K | $-954.0K | $-206.0K | $-613.0K | $-383.0K | $160.0K | $241.0K | |
| Pretax Income | $92M | $-187M | $-153M | $-105M | $-57M | $-46M | $-12M | |
| Income Tax | $5M | $300.0K | $0 | $0 | $2M | $-172.0K | $0 | |
| Net Income | $87M | $-187M | $-153M | $-105M | $-59M | $-45M | $-12M | |
| EPS (Basic) | $2.34 | $-5.00 | $-5.20 | $-4.15 | $-2.52 | $-2.93 | · | |
| EPS (Diluted) | $2.30 | $-5.00 | $-5.20 | $-4.15 | $-2.52 | $-2.93 | · | |
| Shares (Basic) | 37,221,211 | 37,437,652 | 29,447,119 | 25,241,030 | 23,333,914 | 15,506,397 | · | |
| Shares (Diluted) | 37,859,106 | 37,437,652 | 29,447,119 | 25,241,030 | 23,333,914 | 15,506,397 | · | |
| EBITDA | $68M | $-211M | $-170M | $-115M | $-56M | $-47M | · |
Bilans 23
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $287M | $560M | $331M | $279M | $230M | $266M | $7M | |
| Receivables | $4M | $3M | $143.0K | $0 | $18M | $0 | · | |
| Prepaid Expense | $22M | $26M | $16M | $7M | $3M | $2M | $381.0K | |
| Other Current Assets | $2M | $1M | $1M | $276.0K | $210.0K | $160.0K | $215.0K | |
| Current Assets | $315M | $589M | $347M | $286M | $251M | $268M | $9M | |
| PP&E (Net) | $4M | $4M | $4M | $2M | $1M | $724.0K | $708.0K | |
| PP&E (Gross) | $9M | $7M | $6M | $3M | $2M | $1M | $1M | |
| Accum. Depreciation | $4M | $3M | $2M | $1M | $846.0K | $721.0K | $453.0K | |
| Other Non-current Assets | $0 | $2M | $2M | $2M | $82.0K | $0 | · | |
| Total Assets | $338M | $616M | $370M | $307M | $255M | $269M | $11M | |
| Accounts Payable | $2M | $5M | $5M | $3M | $4M | $2M | $2M | |
| Accrued Liabilities | $16M | $21M | $18M | $13M | $7M | $5M | $2M | |
| Current Liabilities | $20M | $27M | $24M | $17M | $12M | $7M | $4M | |
| Capital Leases | $14M | $17M | $13M | $13M | $231.0K | $476.0K | $899.0K | |
| Other Non-current Liabilities | · | · | · | · | $0 | $62.0K | $119.0K | |
| Total Liabilities | $35M | $44M | $38M | $29M | $12M | $8M | $10M | |
| Common Stock | $4.0K | $4.0K | $3.0K | $2.0K | $2.0K | $2.0K | $1.0K | |
| Paid-in Capital | $1.17B | $1.14B | $714M | $506M | $367M | $327M | $203.0K | |
| Retained Earnings | $-482M | $-569M | $-381M | $-228M | $-124M | $-65M | $-20M | |
| Treasury Stock | $385M | $0 | · | · | · | · | · | |
| Stockholders' Equity | $303M | $572M | $332M | $277M | $243M | $262M | $-19M | |
| Liabilities + Equity | $338M | $616M | $370M | $307M | $255M | $269M | $11M | |
| Shares Outstanding | 19,543,706 | 40,554,705 | 31,841,084 | 27,543,453 | 23,974,834 | 23,192,866 | 2,429,705 |
Przepływy pieniężne 12
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $29M | $35M | $29M | $19M | $12M | $4M | $59.0K | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Operating Cash Flow | $108M | $-161M | $-125M | $-70M | $-62M | $-37M | $-16M | |
| CapEx | $2M | $2M | $2M | $1M | $1M | $294.0K | $271.0K | |
| Investing Cash Flow | $-2M | $-2M | $-2M | $-1M | $-1M | $-294.0K | $-271.0K | |
| Stock Issued | · | · | · | · | · | $141M | $0 | |
| Stock Repurchased | $375M | $0 | · | · | · | · | · | |
| Net Stock Activity | $-375M | · | · | · | · | $141M | · | |
| Financing Cash Flow | $-378M | $392M | $179M | $120M | $29M | $296M | $14.0K | |
| Net Change in Cash | $-273M | $229M | $52M | $49M | $-35M | $259M | $-16M | |
| Taxes Paid | $7M | $0 | · | · | · | $0 | $256.0K | |
| Free Cash Flow | $106M | $-163M | $-127M | $-71M | $-63M | $-37M | · |
Rentowność 7
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | 27.7% | -5939.0% | -112543.7% | · | -280.5% | · | · | |
| Net Margin | 35.7% | -5277.6% | -101319.2% | · | -292.3% | · | · | |
| Pretax Margin | 37.7% | -5269.1% | -101319.2% | · | -282.2% | · | · | |
| EBITDA Margin | 27.7% | -5939.0% | -112543.7% | · | -280.5% | · | · | |
| ROA | 18.2% | -38.0% | -45.2% | -37.2% | -22.4% | -32.4% | · | |
| ROE | 17.2% | -33.9% | -48.7% | -40.4% | -25.4% | -23.1% | · | |
| ROIC | 21.1% | -37.0% | -51.1% | -41.4% | -24.0% | -17.8% | · |
Płynność i wypłacalność 2
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 15.5 | 21.5 | 14.2 | 17.3 | 21.2 | 37.3 | · | |
| Quick Ratio | 14.3 | 20.5 | 13.6 | 16.9 | 20.9 | 37.0 | · |
Efektywność 2
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | · | |
| Receivables Turnover | 77.3 | 2.5 | 2.1 | 0.0 | 2.2 | · | · |
Wycena (TTM) 10
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $244M | $0 | $151.0K | $0 | $20M | $0 | · | |
| Net Income TTM | $87M | $-187M | $-153M | $-105M | $-59M | $-45M | · | |
| Market Cap | $398M | $642M | $1.27B | $1.32B | $1.40B | $1.64B | · | |
| P/E | 8.9 | -3.2 | -7.6 | -11.6 | -23.2 | -24.1 | · | |
| P/S | 1.6 | · | 8384.1 | · | 69.8 | · | · | |
| P/B | 1.3 | 1.1 | 3.8 | 4.8 | 5.8 | 6.3 | · | |
| P / Tangible Book | 1.3 | 1.1 | 3.8 | 4.8 | 5.8 | 6.3 | · | |
| P / Cash Flow | 3.7 | -4.0 | -10.2 | -18.9 | -22.6 | -44.3 | · | |
| P / FCF | 3.8 | -3.9 | -10.0 | -18.5 | -22.2 | -44.0 | · | |
| Earnings Yield | 11.3% | -31.6% | -13.1% | -8.6% | -4.3% | -4.2% | · |
Rachunek zysków i strat 14
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $32.0K | $380.0K | $14M | $18M | $211M | $0 | $0 | $0 | $0 | $143.0K | $8.0K | $0 | $0 | $0 | $0 | |
| R&D Expense | $22M | $16M | $18M | $20M | $44M | $49M | $46M | $49M | $41M | $38M | $37M | $34M | $33M | $31M | $25M | $21M | |
| SG&A Expense | $9M | $10M | $12M | $10M | $14M | $10M | $11M | $10M | $10M | $10M | $9M | $9M | $9M | $8M | $7M | $7M | |
| Operating Expenses | $31M | $26M | $30M | $30M | $58M | $59M | $56M | $59M | $50M | $49M | $47M | $43M | $41M | $39M | $32M | $28M | |
| Operating Income | $-31M | $-26M | $-29M | $-15M | $-40M | $152M | $-53M | $-59M | $-50M | $-48M | $-46M | $-43M | $-41M | $-39M | $-32M | $-28M | |
| Other Non-op | $-60.0K | $-166.0K | $273.0K | $-253.0K | $-221.0K | $-338.0K | $-229.0K | $-92.0K | $-196.0K | $-437.0K | $56.0K | $-67.0K | $-155.0K | $-40.0K | $-1M | $762.0K | |
| Pretax Income | $-29M | $-24M | $-25M | $-9M | $-33M | $158M | $-46M | $-53M | $-45M | $-43M | · | · | · | · | $-30M | $-24M | |
| Income Tax | $0 | $0 | $-2M | $-1M | $-2M | $10M | $300.0K | $0 | $0 | $0 | · | · | · | · | $0 | $0 | |
| Net Income | $-29M | $-24M | $-23M | $-7M | $-31M | $148M | $-46M | $-53M | $-45M | $-43M | $-40M | $-39M | $-38M | $-36M | $-30M | $-24M | |
| EPS (Basic) | $-1.45 | $-1.21 | $-0.38 | $-0.18 | $-0.76 | $3.66 | $-1.13 | $-1.41 | $-1.25 | $-1.21 | $-1.34 | $-1.33 | $-1.27 | $-1.26 | $-1.09 | $-0.92 | |
| EPS (Diluted) | $-1.45 | $-1.21 | $-0.38 | $-0.18 | $-0.76 | $3.62 | $-1.13 | $-1.41 | $-1.25 | $-1.21 | $-1.34 | $-1.33 | $-1.27 | $-1.26 | $-1.09 | $-0.92 | |
| Shares (Basic) | 19,800,322 | 19,629,906 | -84,574,415 | 40,623,364 | 40,612,907 | 40,559,355 | -71,941,684 | 37,590,727 | 36,103,187 | 35,685,422 | -58,193,039 | 29,668,247 | 29,602,458 | 28,369,453 | -48,356,346 | 25,549,701 | |
| Shares (Diluted) | 19,800,322 | 19,629,906 | -84,398,490 | 40,623,364 | 40,612,907 | 41,021,325 | -71,941,684 | 37,590,727 | 36,103,187 | 35,685,422 | -58,193,039 | 29,668,247 | 29,602,458 | 28,369,453 | -48,356,346 | 25,549,701 | |
| EBITDA | $-31M | $-26M | · | $-15M | $-40M | $152M | · | $-59M | $-50M | $-48M | · | $-43M | $-41M | $-39M | · | $-28M |
Bilans 22
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $258M | $281M | $287M | $693M | $690M | $721M | $560M | $531M | $406M | $442M | $331M | $288M | $322M | $351M | $279M | $239M | |
| Receivables | $0 | $400.0K | $4M | $3M | $16M | $17M | $3M | $388.0K | $4.0K | $226.0K | $143.0K | · | · | · | · | $0 | |
| Prepaid Expense | $7M | $7M | $22M | $22M | $27M | $22M | $26M | $21M | $27M | $20M | $16M | $17M | $12M | $11M | · | $6M | |
| Other Current Assets | $760.0K | $1M | $2M | $3M | $3M | $3M | $1M | $1M | $582.0K | $616.0K | $1M | $319.0K | $376.0K | $515.0K | · | $745.0K | |
| Current Assets | $267M | $291M | $315M | $719M | $733M | $760M | $589M | $552M | $433M | $463M | $347M | $304M | $334M | $362M | · | $246M | |
| PP&E (Net) | $4M | $4M | $4M | $5M | $5M | $4M | $4M | $4M | $4M | $4M | $4M | $3M | $3M | $3M | · | $2M | |
| PP&E (Gross) | · | · | $9M | · | · | · | $7M | · | · | · | $6M | · | · | · | · | · | |
| Accum. Depreciation | · | · | $4M | · | · | · | $3M | · | · | · | $2M | · | · | · | · | · | |
| Other Non-current Assets | · | · | $0 | $0 | $0 | $463.0K | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $3M | |
| Total Assets | $288M | $312M | $338M | $743M | $757M | $785M | $616M | $579M | $455M | $486M | $370M | $326M | $356M | $384M | · | $253M | |
| Accounts Payable | $2M | $1M | $2M | $2M | $5M | $7M | $5M | $5M | $7M | $5M | $5M | $4M | $4M | $5M | · | $3M | |
| Accrued Liabilities | $8M | $9M | $16M | $15M | $20M | $17M | $21M | $22M | $14M | $13M | $18M | $12M | $12M | $11M | · | $8M | |
| Current Liabilities | $12M | $13M | $20M | $24M | $35M | $39M | $27M | $29M | $21M | $19M | $24M | $17M | $16M | $15M | · | $12M | |
| Capital Leases | $13M | $14M | $14M | $15M | $16M | $16M | $17M | $17M | $13M | $13M | $13M | $14M | $14M | $14M | · | $0 | |
| Total Liabilities | $25M | $27M | $35M | $39M | $50M | $56M | $44M | $46M | $34M | $32M | $38M | $30M | $30M | $29M | · | $12M | |
| Common Stock | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | · | $2.0K | |
| Paid-in Capital | $1.18B | $1.18B | $1.17B | $1.16B | $1.16B | $1.15B | $1.14B | $1.06B | $891M | $878M | $714M | $637M | $628M | $619M | · | $440M | |
| Retained Earnings | $-534M | $-505M | $-482M | $-458M | $-451M | $-420M | $-569M | $-523M | $-470M | $-425M | $-381M | $-341M | $-302M | $-264M | · | $-199M | |
| Treasury Stock | $385M | $385M | $385M | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Stockholders' Equity | $262M | $286M | $303M | $704M | $707M | $729M | $572M | $533M | $421M | $454M | $332M | $296M | $326M | $355M | $277M | $241M | |
| Liabilities + Equity | $288M | $312M | $338M | $743M | $757M | $785M | $616M | $579M | $455M | $486M | $370M | $326M | $356M | $384M | · | $253M | |
| Shares Outstanding | 19,827,188 | 19,732,837 | 19,543,706 | 40,632,164 | 40,615,414 | 40,562,047 | 40,554,705 | 39,258,476 | 36,169,558 | 36,067,786 | 31,841,084 | 29,679,143 | 29,661,005 | 29,548,649 | · | 26,077,204 |
Przepływy pieniężne 9
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $5M | $6M | $7M | $4M | $9M | $9M | $9M | $9M | $9M | $8M | $7M | $9M | $7M | $6M | $5M | $5M | |
| Operating Cash Flow | $-20M | $-4M | $-27M | $3M | $-30M | $161M | $-46M | $-30M | $-40M | $-45M | $-25M | $-34M | $-31M | $-34M | $-21M | $-25M | |
| CapEx | $155.0K | $73.0K | $134.0K | $132.0K | $720.0K | $565.0K | $289.0K | $386.0K | $310.0K | $946.0K | $541.0K | $550.0K | $311.0K | $1M | $351.0K | $176.0K | |
| Investing Cash Flow | $-155.0K | $-73.0K | $-134.0K | $-132.0K | $-720.0K | $-565.0K | $-289.0K | $-386.0K | $-310.0K | $-946.0K | $-541.0K | $-550.0K | $-311.0K | $-1M | $-351.0K | $-176.0K | |
| Stock Issued | · | · | · | · | · | · | · | · | · | $151M | · | $0 | $0 | $107M | · | $48M | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $151M | · | · | · | $107M | · | · | |
| Financing Cash Flow | $-3M | $-2M | $-379M | $140.0K | $17.0K | $4.0K | $76M | $156M | $4M | $157M | $69M | $284.0K | $2M | $108M | $61M | $49M | |
| Net Change in Cash | $-24M | $-6M | $-406M | $3M | $-30M | $161M | $29M | $125M | $-37M | $111M | $43M | $-34M | $-29M | $72M | $40M | $24M | |
| Free Cash Flow | · | $-4M | · | · | · | $161M | · | · | · | $-46M | · | · | · | $-35M | · | · |
Rentowność 7
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -80865.6% | · | -108.9% | -219.2% | 72.0% | · | -15117.8% | -136321.6% | -58413.3% | · | -541000.0% | · | · | · | · | |
| Net Margin | · | -74087.5% | · | -51.5% | -169.0% | 70.3% | · | -13648.4% | -122316.2% | -51944.6% | · | -493000.0% | · | · | · | · | |
| Pretax Margin | · | -74087.5% | · | -61.6% | -181.2% | 75.0% | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | · | -80865.6% | · | -108.9% | -219.2% | 72.0% | · | -15117.8% | -136321.6% | -58413.3% | · | -541000.0% | · | · | · | · | |
| ROA | -5.5% | -4.3% | · | -1.1% | -5.1% | 23.4% | · | -11.7% | -11.2% | -9.9% | · | -13.6% | -12.9% | -11.6% | · | -9.7% | |
| ROE | -5.9% | -4.7% | · | -1.2% | -5.4% | 25.1% | · | -12.8% | -12.1% | -10.7% | · | -14.7% | -14.0% | -12.4% | · | -10.2% | |
| ROIC | -11.8% | -9.1% | · | -1.8% | -5.2% | 19.5% | · | · | · | · | · | · | · | · | · | -11.6% |
Płynność i wypłacalność 2
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 22.0 | 22.6 | · | 29.9 | 21.1 | 19.3 | · | 19.0 | 20.4 | 24.7 | · | 18.2 | 20.8 | 23.4 | · | 21.3 | |
| Quick Ratio | 21.2 | 21.9 | · | 28.9 | 20.3 | 18.7 | · | 18.3 | 19.1 | 23.6 | · | 17.2 | 20.0 | 22.7 | · | 20.8 |
Efektywność 2
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.3 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | · | · | · | 0.0 | |
| Receivables Turnover | 0.0 | 0.0 | · | 7.3 | 2.3 | 24.1 | · | 2.0 | 18.5 | 0.7 | · | · | · | · | · | · |
Wycena (TTM) 10
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $32M | $244M | · | $243M | $229M | $211M | · | $8.0K | $8.0K | $8.0K | · | $8.0K | $0 | · | · | · | |
| Net Income TTM | $-90M | $87M | · | $58M | $20M | $7M | · | $-181M | $-165M | $-156M | · | $-136M | $-124M | $-111M | · | $-95M | |
| Market Cap | $212M | $218M | · | $643M | $542M | $413M | · | $2.28B | $1.65B | $2.39B | · | $946M | $1.19B | $1.26B | · | $981M | |
| P/E | -3.0 | 7.5 | · | 12.5 | 66.8 | -40.8 | · | -11.2 | -9.0 | -13.1 | · | -6.7 | -8.8 | -9.9 | · | -9.6 | |
| P/S | 6.6 | 0.9 | · | 2.6 | 2.4 | 2.0 | · | 284967.5 | 206618.6 | 298460.9 | · | 118271.4 | · | · | · | · | |
| P/B | 0.8 | 0.8 | · | 0.9 | 0.8 | 0.6 | · | 4.3 | 3.9 | 5.3 | · | 3.2 | 3.7 | 3.6 | · | 4.1 | |
| P / Tangible Book | 0.8 | 0.8 | · | 0.9 | 0.8 | 0.6 | · | 4.3 | 3.9 | 5.3 | · | 3.2 | 3.7 | 3.6 | · | 4.1 | |
| P / Cash Flow | · | -61.7 | · | · | · | 2.6 | · | · | · | -53.6 | · | · | · | -36.9 | · | · | |
| P / FCF | · | -60.5 | · | · | · | 2.6 | · | · | · | -52.5 | · | · | · | -35.7 | · | · | |
| Earnings Yield | -33.6% | 13.3% | · | 8.0% | 1.5% | -2.5% | · | -8.9% | -11.1% | -7.7% | · | -15.0% | -11.4% | -10.1% | · | -10.4% |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Przychody | $244M | $0 | $151.0K | $0 | $20M |
| Marża Operacyjna % | 27.7% | -5939.0% | -112543.7% | — | -280.5% |
| Zysk netto | $87M | $-187M | $-153M | $-105M | $-59M |
| Rozwodniony EPS | $2.30 | $-5.00 | $-5.20 | $-4.15 | $-2.52 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wskaźnik bieżący | 15.5 | 21.5 | 14.2 | 17.3 | 21.2 |
| Wskaźnik Szybkości | 14.3 | 20.5 | 13.6 | 16.9 | 20.9 |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $106M | $-163M | $-127M | $-71M | $-63M |
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 149 emitentów · $142.4M łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 21 (-5 vs poprzedni kw.) | 29 (-6 vs poprzedni kw.) | 42 (-3 vs poprzedni kw.) | 46 (-8 vs poprzedni kw.) | +595K |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| Nantahala Capital Management, LLC | $15 091 483 | 1 410 419 | 10,60% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $8 919 477 | 833 596 | 6,26% | Akcje |
| ORBIMED ADVISORS LLC | $8 122 959 | 759 155 | 5,71% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $6 983 195 | 652 635 | 4,90% | Akcje |
| MACKENZIE FINANCIAL CORP | $6 724 287 | 628 438 | 4,72% | Akcje |
| Madison Avenue Partners, LP | $6 704 438 | 626 583 | 4,71% | Akcje |
| Qube Research & Technologies Ltd | $6 514 556 | 608 837 | 4,58% | Akcje |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $6 478 262 | 605 445 | 4,55% | Akcje |
| STATE STREET CORP | $5 790 765 | 541 193 | 4,07% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $4 694 194 | 438 563 | 3,30% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $4 526 357 | 423 024 | 3,18% | Akcje |
| RENAISSANCE TECHNOLOGIES LLC | $3 842 220 | 359 086 | 2,70% | Akcje |
| TWO SIGMA ADVISERS, LP | $3 497 848 | 171 800 | 2,46% | Akcje |
| CITADEL ADVISORS LLC | $3 095 435 | 289 293 | 2,17% | Akcje |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $2 835 682 | 265 017 | 1,99% | Akcje |
| BlackRock, Inc. | $2 790 421 | 260 787 | 1,96% | Akcje |
| ADAR1 Capital Management, LLC | $2 640 953 | 246 818 | 1,85% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $2 639 144 | 246 649 | 1,85% | Akcje |
| VANGUARD GROUP INC | $2 594 882 | 127 450 | 1,82% | Akcje |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $2 494 973 | 233 175 | 1,75% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $1 977 595 | 184 822 | 1,39% | Akcje |
| Cubist Systematic Strategies, LLC | $1 922 605 | 121 530 | 1,35% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1 698 218 | 158 712 | 1,19% | Akcje |
| Man Group plc | $1 664 289 | 155 541 | 1,17% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $1 405 060 | 131 314 | 0,99% | Akcje |
| Connor, Clark & Lunn Investment Management Ltd. | $1 368 370 | 127 885 | 0,96% | Akcje |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $1 352 255 | 126 379 | 0,95% | Akcje |
| Nebula Research & Development LLC | $1 206 920 | 90 406 | 0,85% | Akcje |
| AMERIPRISE FINANCIAL INC | $1 084 360 | 101 342 | 0,76% | Akcje |
| GOLDMAN SACHS GROUP INC | $942 221 | 88 058 | 0,66% | Akcje |
| AMERICAN CENTURY COMPANIES INC | $906 076 | 84 680 | 0,64% | Akcje |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $902 781 | 84 372 | 0,63% | Akcje |
| HSBC HOLDINGS PLC | $761 494 | 69 926 | 0,53% | Akcje |
| MARTINGALE ASSET MANAGEMENT L P | $725 418 | 67 796 | 0,51% | Akcje |
| RBF Capital, LLC | $671 960 | 62 800 | 0,47% | Akcje |
| AlphaQuest LLC | $653 352 | 32 090 | 0,46% | Akcje |
| Bank of New York Mellon Corp | $646 869 | 60 455 | 0,45% | Akcje |
| XTX Topco Ltd | $636 982 | 59 531 | 0,45% | Akcje |
| Jain Global LLC | $633 536 | 59 209 | 0,44% | Akcje |
| PANAGORA ASSET MANAGEMENT INC | $599 040 | 55 985 | 0,42% | Akcje |
| IEQ CAPITAL, LLC | $595 723 | 55 675 | 0,42% | Akcje |
| JANE STREET GROUP, LLC | $583 557 | 54 538 | 0,41% | Akcje |
| Rangeley Capital, LLC | $582 080 | 54 400 | 0,41% | Akcje |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | $538 467 | 50 324 | 0,38% | Akcje |
| BNP PARIBAS FINANCIAL MARKETS | $533 406 | 49 851 | 0,37% | Akcje |
| Y-Intercept (Hong Kong) Ltd | $515 483 | 48 176 | 0,36% | Akcje |
| BARCLAYS PLC | $509 576 | 47 624 | 0,36% | Akcje |
| DEUTSCHE BANK AG\ | $500 781 | 46 802 | 0,35% | Akcje |
| Susquehanna Portfolio Strategies, LLC | $479 617 | 44 824 | 0,34% | Akcje |
| Mariner, LLC | $416 218 | 38 895 | 0,29% | Akcje |
| D. E. Shaw & Co., Inc. | $386 602 | 36 131 | 0,27% | Akcje |
| FMR LLC | $378 010 | 35 328 | 0,27% | Akcje |
| PRELUDE CAPITAL MANAGEMENT, LLC | $374 917 | 35 039 | 0,26% | Akcje |
| MARSHALL WACE, LLP | $370 220 | 34 600 | 0,26% | Akcje |
| ALLIANCEBERNSTEIN L.P. | $366 528 | 33 200 | 0,26% | Akcje |
| RHUMBLINE ADVISERS | $350 471 | 32 755 | 0,25% | Akcje |
| BANK OF AMERICA CORP /DE/ | $334 161 | 31 230 | 0,23% | Akcje |
| Squarepoint Ops LLC | $333 883 | 31 204 | 0,23% | Akcje |
| MERCER GLOBAL ADVISORS INC /ADV | $296 219 | 27 684 | 0,21% | Akcje |
| Quantinno Capital Management LP | $288 590 | 26 971 | 0,20% | Akcje |
| Advantage Alpha Capital Partners LP | $285 693 | 18 059 | 0,20% | Akcje |
| FEDERATED HERMES, INC. | $268 153 | 25 061 | 0,19% | Akcje |
| CANADA PENSION PLAN INVESTMENT BOARD | $247 170 | 23 100 | 0,17% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $225 160 | 21 043 | 0,16% | Akcje |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $210 524 | 17 841 | 0,15% | Akcje |
| MORGAN STANLEY | $188 518 | 17 618 | 0,13% | Akcje |
| Creative Planning | $178 776 | 16 708 | 0,13% | Akcje |
| MetLife Investment Management, LLC | $178 497 | 16 682 | 0,13% | Akcje |
| Empowered Funds, LLC | $177 984 | 16 634 | 0,13% | Akcje |
| WELLS FARGO & COMPANY/MN | $165 636 | 15 480 | 0,12% | Akcje |
| Jump Financial, LLC | $164 780 | 15 400 | 0,12% | Akcje |
| EJF Capital LP | $160 500 | 15 000 | 0,11% | Akcje |
| EDBI Pte Ltd | $159 962 | 10 105 | 0,11% | Akcje |
| CITADEL ADVISORS LLC | $154 080 | 14 400 | 0,11% | Opcja sprzedaży |
| nVerses Capital, LLC | $140 426 | 13 124 | 0,10% | Akcje |
| Cerity Partners LLC | $136 308 | 12 739 | 0,10% | Akcje |
| Engineers Gate Manager LP | $130 701 | 12 215 | 0,09% | Akcje |
| PDT Partners, LLC | $122 034 | 11 405 | 0,09% | Akcje |
| Point72 Asset Management, L.P. | $111 205 | 10 393 | 0,08% | Akcje |
| AMERICAN FINANCIAL GROUP INC | $108 124 | 10 105 | 0,08% | Akcje |
| Arax Advisory Partners | $107 503 | 10 047 | 0,08% | Akcje |
| NEW YORK STATE COMMON RETIREMENT FUND | $97 541 | 9 116 | 0,07% | Akcje |
| CWM, LLC | $95 143 | 8 618 | 0,07% | Akcje |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $91 068 | 8 511 | 0,06% | Akcje |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $85 311 | 7 973 | 0,06% | Akcje |
| CITIGROUP INC | $85 044 | 7 948 | 0,06% | Akcje |
| Vanguard Global Advisers, LLC | $85 012 | 7 945 | 0,06% | Akcje |
| Police & Firemen's Retirement System of New Jersey | $82 390 | 7 700 | 0,06% | Akcje |
| Invesco Ltd. | $81 170 | 7 586 | 0,06% | Akcje |
| JPMORGAN CHASE & CO | $75 865 | 6 941 | 0,05% | Akcje |
| NISA INVESTMENT ADVISORS, LLC | $42 682 | 3 989 | 0,03% | Akcje |
| China Universal Asset Management Co., Ltd. | $33 705 | 3 150 | 0,02% | Akcje |
| IFP Advisors, Inc | $32 239 | 3 013 | 0,02% | Akcje |
| NORTHERN TRUST CORP | $30 977 | 2 895 | 0,02% | Akcje |
| Ameritas Investment Partners, Inc. | $25 380 | 2 372 | 0,02% | Akcje |
| OSAIC HOLDINGS, INC. | $21 421 | 2 002 | 0,02% | Akcje |
| Tower Research Capital LLC (TRC) | $21 036 | 1 966 | 0,01% | Akcje |
| Legal & General Group Plc | $20 747 | 1 939 | 0,01% | Akcje |
| AQR CAPITAL MANAGEMENT LLC | $19 795 | 1 850 | 0,01% | Akcje |
| Point72 Asia (Singapore) Pte. Ltd. | $19 554 | 1 236 | 0,01% | Akcje |
Insiderzy spółki 17 insiderów · 6 dyrektorzy generalni · 12 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Jasbir Seehra | Chief Executive Officer | 8 kwietnia 2023 M | 252 856 | 0 | 0 | $0 |
| Keith Regnante | Chief Financial Officer | 4 stycznia 2024 M | 0 | 0 | 0 | $0 |
| Christopher Rovaldi | Chief Operating Officer | 16 lutego 2023 A | 0 | 0 | 0 | $0 |
| Simon Peter Cooper | Chief Medical Officer | 16 lutego 2023 A | — | 0 | 0 | $0 |
| Jennifer Lachey | Chief Scientific Officer | 15 lipca 2022 M | 95 100 | 0 | 0 | $0 |
| Claudia Ordonez | Chief Medical Officer | 11 czerwca 2021 M | 0 | 0 | 0 | $0 |
| Jean Jacques Bienaime | Dyrektor | 15 lipca 2026 P | 18 592 | 5 | 0 | $65 500 |
| Anne Prener | Dyrektor | 1 lipca 2026 A | 13 786 | 0 | 0 | $0 |
| Charles W. Newton | Dyrektor | 11 czerwca 2026 S | 12 665 | 0 | 1 | $-5 522 |
| Julius Knowles | Dyrektor | 4 czerwca 2026 S | 10 958 | 0 | 1 | $-28 166 |
| Nima Farzan | Dyrektor | 4 czerwca 2026 S | 9 767 | 0 | 1 | $-28 166 |
| Alpna Seth | Dyrektor | 4 czerwca 2026 S | 9 767 | 0 | 1 | $-28 140 |
| Mary Ann Gray | Dyrektor | 3 czerwca 2026 A | 12 392 | 0 | 0 | $0 |
| GORDON CARL L | Dyrektor | 21 listopada 2025 D | 45 057 | 0 | 0 | $0 |
| Ran Nussbaum | Dyrektor | 6 czerwca 2023 A | 1 226 412 | 0 | 0 | $0 |
| Tomer Kariv | Dyrektor | 6 czerwca 2023 A | 1 226 412 | 0 | 0 | $0 |
| Alon Lazarus | Dyrektor | 13 kwietnia 2020 C | 2 013 102 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Aktywiści i właściciele 5%+ 4 akcje
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Pontifax Management 4 GP (2015) Ltd., Pontifax (Israel) IV, L.P., Pontifax (Cayman) IV, L.P., Pontifax (China) IV, L.P., Pontifax Late Stage Fund L.P., Pontifax Late Stage GP Ltd. ×3 zgłoszenia | 16 października 2025 | 0,00% | Aneks | — | SEC |
| ADAR1 Capital Management, LLC, ADAR1 Capital Management GP, LLC, Daniel Schneeberger ×6 zgłoszenia | 15 października 2025 | 0,00% | Aneks | — | SEC |
| OrbiMed Advisors LLC, OrbiMed Capital GP VII LLC, OrbiMed Genesis GP LLC, OrbiMed Capital LLC ×4 zgłoszenia | 13 grudnia 2023 | — | Pierwotne zgłoszenie | — | SEC |
| Arkin Bio Ventures Limited Partnership, Arkin Bio Venture Partners Ltd., Moshe Arkin, Alon Lazarus ×3 zgłoszenia | 17 grudnia 2020 | — | Pierwotne zgłoszenie | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Posiadanie ETF-ów Posiadane przez 37 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,38% | 12 830 NS | 30 kwietnia 2026 | N-PORT |
| OASC · Unified Series Trust | 0,20% | 15 034 NS | 31 maja 2026 | N-PORT |
| FSCC · Federated Hermes ETF Trust | 0,10% | 23 576 NS | 31 maja 2026 | N-PORT |
| IWC · iShares Trust | 0,05% | 63 474 SH | 8 sierpnia 2026 | Dziennie |
| GSSC · Goldman Sachs ETF Trust | 0,04% | 38 819 NS | 31 maja 2026 | N-PORT |
| SMLF · iShares Trust | 0,03% | 104 137 SH | 8 sierpnia 2026 | Dziennie |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,02% | 6 426 SH | 8 sierpnia 2026 | Dziennie |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,02% | 55 956 SH | 8 sierpnia 2026 | Dziennie |
| VFVA · VANGUARD WELLINGTON FUND | 0,02% | 17 295 SH | 8 sierpnia 2026 | Dziennie |
| SFGV · EA Series Trust | 0,02% | 16 659 NS | 29 maja 2026 | N-PORT |
| BIB · ProShares Trust | 0,02% | 1 125 NS | 31 maja 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,02% | 1 074 SH | 8 sierpnia 2026 | Dziennie |
| IBB · iShares Trust | 0,01% | 132 792 SH | 8 sierpnia 2026 | Dziennie |
| IWN · iShares Trust | 0,01% | 172 816 SH | 8 sierpnia 2026 | Dziennie |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,01% | 27 974 NS | 31 maja 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 106 081 SH | 8 sierpnia 2026 | Dziennie |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 16 122 SH | 8 sierpnia 2026 | Dziennie |
| RSSL · Global X Funds | 0,01% | 12 811 NS | 30 kwietnia 2026 | N-PORT |
| DFSV · Dimensional ETF Trust | 0,01% | 63 454 NS | 30 kwietnia 2026 | N-PORT |
| ITWO · ProShares Trust | 0,01% | 1 375 NS | 31 maja 2026 | N-PORT |
| IWM · iShares Trust | 0,01% | 465 257 SH | 8 sierpnia 2026 | Dziennie |
| DFAS · Dimensional ETF Trust | 0,01% | 65 248 NS | 30 kwietnia 2026 | N-PORT |
| UWM · ProShares Trust | 0,00% | 1 075 NS | 31 maja 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,00% | 92 945 NS | 31 maja 2026 | N-PORT |
| URTY · ProShares Trust | 0,00% | 1 085 NS | 31 maja 2026 | N-PORT |
| AVUV · AMERICAN CENTURY ETF TRUST | 0,00% | 83 474 NS | 31 maja 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 1 190 NS | 31 maja 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 27 NS | 31 maja 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 20 827 NS | 30 kwietnia 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 7 079 SH | 8 sierpnia 2026 | Dziennie |
| DFAT · Dimensional ETF Trust | 0,00% | 4 070 NS | 30 kwietnia 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 11 035 NS | 31 maja 2026 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0,00% | 1 224 NS | 31 maja 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 220 854 SH | 8 sierpnia 2026 | Dziennie |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 595 316 SH | 8 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 980 SH | 8 sierpnia 2026 | Dziennie |
| VHT · VANGUARD WORLD FUND | 0,00% | 49 290 SH | 8 sierpnia 2026 | Dziennie |